Candriam SCA’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.26M Sell
148,595
-10,504
-7% -$513K 0.04% 298
2025
Q1
$8.11M Sell
159,099
-1,010
-0.6% -$51.5K 0.05% 264
2024
Q4
$7.23M Sell
160,109
-8,111
-5% -$366K 0.04% 305
2024
Q3
$6.24M Buy
+168,220
New +$6.24M 0.04% 324
2024
Q2
Sell
-167,048
Closed -$4.86M 718
2024
Q1
$4.86M Sell
167,048
-124,604
-43% -$3.62M 0.03% 347
2023
Q4
$8.04M Hold
291,652
0.06% 281
2023
Q3
$6.54M Hold
291,652
0.05% 282
2023
Q2
$11.9M Buy
291,652
+14,000
+5% +$569K 0.09% 223
2023
Q1
$12.4M Buy
277,652
+75,000
+37% +$3.34M 0.09% 229
2022
Q4
$7.73M Hold
202,652
0.05% 315
2022
Q3
$10.2M Hold
202,652
0.07% 267
2022
Q2
$8.12M Sell
202,652
-70,722
-26% -$2.83M 0.07% 257
2022
Q1
$10.2M Hold
273,374
0.07% 256
2021
Q4
$10.9M Hold
273,374
0.07% 252
2021
Q3
$10.2M Hold
273,374
0.07% 270
2021
Q2
$11.6M Sell
273,374
-326,023
-54% -$13.8M 0.08% 269
2021
Q1
$35.1M Hold
599,397
0.29% 84
2020
Q4
$36.6M Sell
599,397
-150,563
-20% -$9.19M 0.29% 84
2020
Q3
$35.1M Sell
749,960
-24,000
-3% -$1.12M 0.33% 67
2020
Q2
$39.3M Buy
773,960
+171,970
+29% +$8.73M 0.41% 51
2020
Q1
$28.3M Hold
601,990
0.31% 66
2019
Q4
$28.9M Sell
601,990
-88,533
-13% -$4.25M 0.31% 66
2019
Q3
$23.4M Buy
690,523
+50,000
+8% +$1.69M 0.31% 62
2019
Q2
$28.7M Buy
640,523
+178,000
+38% +$7.97M 0.36% 56
2019
Q1
$17.4M Buy
462,523
+60,000
+15% +$2.26M 0.22% 101
2018
Q4
$13.8M Buy
402,523
+77,000
+24% +$2.64M 0.21% 111
2018
Q3
$15.3M Buy
325,523
+169,523
+109% +$7.97M 0.2% 117
2018
Q2
$5.26M Buy
156,000
+34,000
+28% +$1.15M 0.08% 287
2018
Q1
$3.3M Buy
122,000
+35,000
+40% +$947K 0.06% 367
2017
Q4
$1.45M Buy
87,000
+27,000
+45% +$450K 0.03% 515
2017
Q3
$1.2M Buy
+60,000
New +$1.2M 0.02% 542
2016
Q1
Sell
-59,000
Closed -$1.91M 649
2015
Q4
$1.91M Sell
59,000
-15,000
-20% -$486K 0.05% 302
2015
Q3
$1.98M Buy
74,000
+8,000
+12% +$214K 0.05% 344
2015
Q2
$3.18M Sell
66,000
-31,000
-32% -$1.49M 0.07% 302
2015
Q1
$5.9M Sell
97,000
-3,000
-3% -$183K 0.12% 229
2014
Q4
$5.18M Buy
+100,000
New +$5.18M 0.11% 224